Ardelyx
ARDX
$6.61
Share price
3.28%
Change (1 day)
42.15%
Change (1 year)
Categories
Ardelyx (ARDX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.13 B
According to Ardelyx's latest financial reports the company's total liabilities are $0.13 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Ardelyx - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | 42.54% |
| 2022-12-31 | $91.73 M | 36.32% |
| 2021-12-31 | $67.29 M | -10.81% |
| 2020-12-31 | $75.45 M | 3.18% |
| 2019-12-31 | $73.12 M | 8.31% |
| 2018-12-31 | $67.51 M | 263.18% |
| 2017-12-31 | $18.59 M | -6.95% |
| 2016-12-31 | $19.98 M | 148.35% |
| 2015-12-31 | $8.04 M | -84.74% |
| 2014-12-31 | $52.73 M | 4.99% |
| 2013-12-31 | $50.22 M | 28.39% |
| 2012-12-31 | $39.12 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $34.38 B | 26,197.19% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 69,431.90% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 43,959.10% | 🇫🇷 France |
 AstraZeneca AZN | $64.79 B | 49,449.18% | 🇬🇧 UK |
 OPKO Health
OPK | $0.62 B | 376.04% | 🇺🇸 USA |